Need professional-grade analysis? Visit stockanalysis.com
$867.85M
N/A
N/A
N/A
Nanosonics Limited (NNCSF) trades on United States in USD. The company is classified in the Healthcare sector under the Medical Instruments & Supplies industry. The stock currently trades at $2.80.
Over the past year, NNCSF has traded between a low of $2.19 and a high of $3.20. The stock has lost 5.1% over this period. It is currently 12.5% below its 52-week high.
Nanosonics Limited has a market capitalization of $867.85M.
Nanosonics Limited operates as an infection prevention company in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. The company manufactures and distributes trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. It also provides trophon2 a device with an enhanced design and new functionality, including AcuTrace TM for audit-ready digital record-keeping and capabilities to connect trophon 2 with hospital IT systems; AuditPro nanosonics, an infection control workflow compliance management; Trophon EPR, a patented sonicated mist technology that provides high level disinfection of both endocavitary and surface ultrasound probes; and CORIS, an instrument reprocessing product platform. Nanosonics Limited was incorporated in 2000 and is headquartered in Macquarie Park, Australia.
Side-by-side comparison against top Healthcare peers.